A Dying Breed

Redistribution of federal financial backing may have drastic implications for cancer studies, they warn With federal research funds increasingly being earmarked for such publicly visible areas of biomedical investigation as AIDS and women's health, cancer research institutions in the United States are finding themselves in a bind. Saddled with a shrinking piece of the budgetary pie, heads of the nation's basic cancer research cente

Written bySteven Benowitz
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Saddled with a shrinking piece of the budgetary pie, heads of the nation's basic cancer research centers are struggling to maintain their high scientific standards while making ends meet. They worry that the frustration of stagnant funding levels will drive their best researchers to seek greener pastures. And they are concerned that, in the long run, the necessity of cutting costs will serve only to hinder scientific progress.

The Wistar Institute of Anatomy and Biology in Philadelphia shares the woes of other basic science cancer centers: how to deal with an uncertain funding environment, given the increased push by federal funding agencies to support applied research.

Compounding matters, Wistar has had the added burden of a three-year legal battle over management issues with former director Hilary Koprowski, settled in June 1993. Although just three years ago Wistar faced a $2 million budget deficit and declining morale, today the staff credits ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA